PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.

NCT05175742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

565

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19 Vaccine

Interventions

BIOLOGICAL: PTX-COVID19-B
BIOLOGICAL: Pfizer-BioNTech COVID-19 vaccine
BIOLOGICAL: Placebo

Sponsor

Providence Therapeutics Holdings Inc.